ORTEXORTEX News
Tracking PCG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PC
Earnings PreviewPCG

PG&E Insiders Sell Into a Softening Stock

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 18 May 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of PG&E Corporation (PCG) share price and short interest (% of free float), three months to May 14, 2026
ORTEX data as of 18 May 2026, 04:00

PCG heads into its May 21 Q1 print with a notable insider selling pattern and a stock that has lost momentum — a combination that sharpens the scrutiny on what management delivers.

The insider signal is hard to ignore. CEO Patricia Poppe sold $512,000 worth of shares on April 28, at $16.39. That same day, an EVP sold a further $773,000. The net insider activity over the past 90 days runs positive in headline share count — largely due to an award grant in March — but the cash-sale picture is one-directional: every discretionary transaction has been a sale. The stock has since slipped further, now trading at $16.13, down 8% over the past month. Insiders were selling at prices that now look elevated.

The bull and bear divide is essentially a debate about rate sensitivity and regulatory risk versus valuation. The Street leans constructive — analyst consensus implies 41% upside to the mean target of ~$22.70, and the dividend-score factor ranks in the 88th percentile. JP Morgan maintained its Overweight on May 15 but trimmed its target to $23 from $24, a modest acknowledgement that near-term pressure has increased. UBS upgraded to Buy in March and Truist initiated at Buy in April, so multiple fresh buy-side voices have entered the name. Jefferies is the outlier, having downgraded to Hold in March with a $19 target — the firmest bearish stance among bellwether firms. The bear case centres on PCG's $64.7 billion net debt load, heavy capex ($12.5 billion annually), and the stock's tendency to re-rate lower when macro rates move against utilities.

Options traders are leaning unusually bullish, not defensive. The put/call ratio has dropped to 0.17, well below its 20-day average of 0.20 and near the 52-week low of 0.13. That is more call-heavy positioning than usual for a stock that is down on the month — a divergence worth watching. Short sellers have been heading for the exits: short interest has fallen 12% over the past week and 18% over the past month to just 1.6% of the free float. Borrow is essentially free at 0.35% annualised, and availability remains wide. There is no squeeze dynamic in play, and short pressure is clearly not driving the recent price weakness.

The broader utility sector offered no shelter either. Peers EIX, DUK and XEL all fell 2–3% on the last trading day alongside PCG — sector-wide pressure that frames the May 21 print less as a company-specific event and more as a referendum on the utility sector's place in a higher-for-longer rate environment.

The earnings print will test whether PCG's recovery narrative — rate base growth, wildfire liability management, and operating leverage — can hold the stock's valuation floor at a P/E of roughly 9.5x at a time when the CEO's own selling and a softening tape suggest reduced conviction at the top.

Against its own history

This week's change in short interest is 1.8 standard deviations above the company's typical weekly move over the past year.

Against its peers

Shares moved +0.4% over the past week against a median of -1.7% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open PCG on ORTEX →

How this article was generated

Generated
18 May 2026, 04:08
Data as of
18 May 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.